Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study
Titel:
Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study
Auteur:
del Barco Morillo, Elvira Mesía, Ricard Adansa Klain, Juan Carlos Vázquez Fernández, Silvia Martínez-Galán, Joaquina Pastor Borgoñon, Miguel González-Rivas, Cyntia Caballero Daroqui, Javier Berrocal, Alfonso Martínez-Trufero, Javier Vera, Ruth Cruz-Hernández, Juan Jesús